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A set of 415 clinical samples isolated from 294 patients su­
spected of having syphilis collected in the Czech Repub­
lic between 2004 and 2010 was tested for the presence of 
treponemal DNA. Standard serological tests showed that 
197 patients were syphilis­seropositive and 97 patients 
were syphilis­seronegative. In each sample, PCR tests 
for polA (TP0105), tmpC (TP0319), TP0136, TP0548 and 
23S rRNA genes were performed. Samples taken from 
91 patients were PCR­positive. Molecular typing of tre­
ponemal DNA was based on the sequencing of TP0136, 
TP0548 and 23S rRNA genes. Treponemal DNA was ty­
peable in samples taken from 64 PCR­positive patients 
and 9 different genotypes were found. The proportion of 
treponemal strains resistant to macrolide antibiotics was 
37.3%. In the DNA samples taken from 39 patients, a pa­
rallel treponemal typing approved by Centers for Disease 
Control and Prevention was performed. The variants of 
arp and tpr genes appear to combine independently with 
sequence variants of TP0136, TP0548 and 23S rRNA ge­
nes. Key words: Treponema pallidum; syphilis; molecular 
typing; macrolide resistance; nested PCR.
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Treponema pallidum subspecies pallidum is the causa-
tive agent of syphilis, a sexually transmitted disease that 
has been known in Europe for more than 500 years. On 
a global scale, it is believed that more than 12 million 
syphilis infections occur each year (1). Introduction of 
antibiotic therapy in the middle of the last century and 
relatively strict prevention programmes offered by healt-
hcare providers decreased the incidence of syphilis in the 
Czech Republic to its lowest recorded level in 1990, with 
1.6 cases per 100,000 inhabitants per year (2), which was 
two orders of magnitude lower than the mean worldwide 
incidence of syphilis. Since 1990, the opening of the 
Czechoslovakian borders and increased travel, together 
with relaxed preventive measures, have resulted in a more 
than eight-fold increase in syphilis cases, which reached 
13.4 syphilis cases per 100,000 inhabitants per year in 
2001 (3). Until 2003, the number of syphilis cases in the 
Czech Republic remained proportional among female and 
male populations. Since 2004 there has been an increasing 
number of syphilis cases in the male population, especially 
in the men having sex with men (MSM) community. In 
2009, almost twice as many syphilis cases were diagnosed 
among men compared with women (4, 5).
Although serological methods are considered to be the 
standard in syphilis diagnostics, there is an increasing 
trend in using PCR-based methods to diagnose syphi-
lis (6–14), which allows additional molecular typing 
of syphilis treponemes. Treponemal sequence data 
(15–18) from T. pallidum ssp. pallidum and other related 
treponemes revealed chromosomal target sequences 
including TP0136, TP0326, TP0488 and TP0548 genes, 
potentially suitable for genotyping of T. pallidum. Seve-
ral molecular subtyping methods have been described 
for T. pallidum, including amplification of TP0433 (arp) 
and restriction fragment length polymorphism (RFLP) 
analysis of TP0313 (tprE), TP0317 (tprG), TP0621 
(tprJ) genes (19), sequencing of TP0136 and TP0548 
amplicons (20), and sequencing of the tprK gene (21, 
22). Recently, an enhanced T. pallidum strain typing 
CDC method, based on arp and tpr amplification and 
sequencing of TP0548, was introduced and has become 
the most effective treponemal typing system (23). 
In this report we present data on molecular detection and 
typing of T. pallidum strains found in patients in the Czech 
Republic from 2004 to 2010. Isolated treponemal DNA 
was typed by sequencing of three target chromosomal loci 
including TP0136, TP0548 and 23S rRNA genes.
MATERIALS AND METhODS
Collection of clinical samples
Clinical samples were collected throughout the Czech Republic 
from 2004 to 2010. Five clinical departments in the Czech Re-
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public were involved in sample collection and serology testing, 
namely the Department of Microbiology and Department of Der-
matovenerology, St Anne’s University hospital; the Department 
of Dermatovenerology, Faculty hospital Brno; the Department 
of Dermatology and Venerology, General University hospital in 
Prague; and the National Reference Laboratory for Diagnostics 
of Syphilis, The National Institute for Public health. Both groups 
of syphilis-seropositive and syphilis-seronegative patients were 
used. The seronegative patients had probable contacts with sero-
positive persons or were suspected of having syphilis infections. 
All clinical samples were obtained after the patient’s informed 
consent. The design of the study was approved by the ethics com-
mittee of the Faculty of Medicine, Masaryk University. 
Isolation of treponemal DNA
Swab supernatant (0.2–0.4 ml), whole blood (0.2–0.8 ml) and 
blood serum (0.2–0.8 ml) were used for isolation of DNA using 
QIAamp DNA Blood Mini kit (Qiagen, hilden, Germany) 
according to manufacturer’s recommended protocol (Blood 
and Body Fluid Spin Protocol). DNA from other samples (e.g. 
cerebrospinal fluid, knee fluid) was handled in the same way 
as the swab supernatants, with the exception of tissue samples, 
which were isolated using the Tissue protocol.
Molecular detection of treponemal DNA
A nested PCR detection of polA (TP0105) and tmpC (TP0319) 
genes was performed as described previously (12, 20, 24). 
TP0136, TP0548 and 23S rRNA genes were amplified using 
nested PCR according to Matějková et al. (25). Briefly, each 
25 µl PCR reaction contained 0.5 µl of 10 mM dNTP mix, 2.5 
µl of 10× ThermoPol Reaction buffer, 0.25 µl of each primer 
(100 pmol/µl), 0.05 µl of Taq polymerase (5,000 U/ml, New 
England BioLabs, Frankfurt am Main, Germany), 1–10 µl of 
tested sample and variable amounts of PCR-grade water. PCR 
amplification was performed at the following cycling condi-
tions: 94ºC (1 min); 94ºC (30 s), 48ºC (30 s), 72ºC (60 s), 30 
cycles; 72ºC (7 min) for TP0136, TP0548 and 23S rRNA genes. 
The second step of nested PCR was performed under the same 
conditions, but with an increased number of cycles (40 cycles). 
For determination of mutations at position 2058 (26, 27) and 
2059 (25) in the 23S rRNA gene, which cause macrolide resis-
tance, a MboII/BsaI restriction digest assay was used (25). The 
number of 60-bp repetitions in the arp gene was determined as 
described by Marra et al. (23) and amplification of tprE, G, and 
J genes, using nested PCR, was done according to Pillay et al. 
(19) with two modifications, (i) increase of the PCR extension 
temperature (from 68ºC to 72ºC) and (ii) the use of GoTaq 
Flexi DNA polymerase (Promega, Mannheim, Germany), as 
described by Marra et al. (23). The RFLP analysis of tpr genes 
was performed according to Pillay et al. (19). 
DNA sequencing and assembly of consensus sequences
PCR products were sequenced using Taq DyeDeoxy Terminator 
Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, 
USA); 570–1,188 bp (median length 1,131 bp, mean length 1,100 
bp) and 522–1,067 bp (median length 1,007 bp, mean length 
940.5 bp) were evaluated in a set of 66 amplicons (n = 53) and 
72 amplicons (n = 60) of TP0136 and TP0548 sequences, respec-
tively. Sequences of 92 individual amplicons (n = 75) of the 23S 
rRNA gene were evaluated only at positions corresponding to 
positions 2058 and 2059 in the 23S rRNA gene of E. coli. 
Statistical methods
STATISTICA version 8.0 (StatSoft, Tulsa, OK, USA) was used 
for calculations of statistical significances. Standard methods 
derived from the binomial distribution, including the two-tailed 
test were used. An interactive calculation tool for χ2 tests of 
“goodness of fit” and independence was used (28).
RESULTS
Characteristics of clinical samples
From 2004 to 2010, 277 samples taken from 197 
syphilis-seropositive patients and 138 samples taken 
from 97 syphilis-seronegative patients were tested for 
the presence of treponemal DNA using PCR amplifi-
cation of several chromosomal loci. Three out of 97 
patients with negative serology were found to be PCR-
positive for treponemal DNA, probably reflecting early 
stages of treponemal infection. In total, 119 samples 
from 91 patients were PCR-positive for treponemal 
DNA. In each sample, 5 treponemal genes (polA 
(TP0105), tmpC (TP0319), TP0136, TP0548 and 23S 
rRNA) were tested and samples were considered posi-
tive when PCR amplifications were positive in at least 
two independent treponemal loci. Seventeen, 12 and 
18 patients were PCR-positive in 2, 3 and 4 treponemal 
loci, respectively. All 5 tested genes were detected in 
samples taken from 44 patients. polA and tmpC, 23S 
rDNA, TP0548, and TP0136 were detected in samples 
taken from 87, 75, 60, and 53 patients, respectively.
A high number of seropositive, but PCR-negative 
patients were detected (55.3%). The PCR-negative 
blood samples taken from seropositive patients were 
tested for the presence of the human methylenetetra-
hydrofolate reductase (MThFR) gene as described 
previously (29). Out of 51 tested whole blood samples, 
47 (92.2%) were PCR-positive for the MThFR gene. 
The relatively high number of PCR-negative specimens 
taken from seropositive patients thus reflects undetec-
table amounts of treponemal DNA than the presence 
of PCR inhibitors. 
Several different types of clinical material taken from 
patients that fulfil our syphilis criteria (i.e. patients 
with positive syphilis serology and/or with positive 
PCR detection of treponemal DNA) were analysed. 
The highest incidence of PCR-positive samples were 
found in genitoanal, oropharyngeal and skin swabs from 
mucocutaneous efflorescences (75 positive swabs out of 
116; 64.7%), followed by whole blood samples (26.8%) 
and other samples (22.2%) including blood serum, ce-
rebrospinal fluid, knee aspirate and tissue samples. 
Characteristics of patients with syphilis 
To further analyse patients considered to have syphi-
lis, both groups of PCR-positive and PCR-negative 
patients were analysed with respect to a number of 
additional parameters (Table I). Patients with PCR-
positive samples were more often in the primary stage 
of syphilis (64.8%) than patients with negative PCR 
results (39.0%; p = 0.0003), while the opposite was 
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found for the latent syphilis stage (8.8% and 31.4%, 
respectively; p = 0.0001). 
PCR detection and molecular typing of syphilis 
treponemes 
The results of molecular typing of treponemes are shown 
in Tables II and III. Treponemal DNA was completely 
typed in samples taken from 49 (out of 91) patients, i.e. 
sequences of all 3 loci including TP0136, TP0548 and 
23S rDNA were determined. In additional samples from 
15 patients, either TP0136 (11 patients) or TP0548 (4 
patients) gene was not amplified or sequenced. Nine diffe-
rent genotypes were identified among treponemal samp-
les with typeable DNA isolated from 64 patients. Geno-
types were marked by a three-letter code, where the first 
letter stands for TP0136 sequence (S, identical to SS14; 
U1, unique sequence 1; X, not determined), the second 
letter stands for TP0548 sequence (S, identical to SS14; 
U1, unique sequence 1; X, not determined), and the third 
letter stands for sensitivity to macrolide antibiotics (S, 
sensitive; R8, mutation A2058G; R9, mutation A2059G). 
The prevailing genotype was sequentially identical at the 
TP0136 and TP0548 loci to the SS14 strain (16, 30), but 
unlike the SS14 strain, the 23S rDNA sequence encoded 
sensitivity to macrolide antibiotics (26). This genotype 
(SSS) was found in 31 out of 49 (63.3%) strains. Two 
additional genotypes (SSR8 and SSR9) found in samples 
from 3 and 6 patients, differed only in the presence of 
A2058G and A2059G mutations in the 23S rRNA gene, 
respectively. The SU2R8 genotype comprised treponemal 
samples taken from six patients and was sequentially 
unique at the TP0548 locus (unique 2, Fig. 1). All other 
identified genotypes (U1SS, U2SS, SU1S, XU3R8, and 
XU4R9) were represented by a single strain. 
In 44 samples taken from 39 patients, additional ty-
ping was performed according to Pillay et al. (19). Using 
this typing scheme, 3 out of 4 most abundant genotypes 
(SSS, SSR8, and SSR9) can be further classified to 2 
to 4 additional subgroups (Table II). Using both typing 
Table I. Parameters of syphilis patients with positive and negative results of PCR detection of treponemal DNA from whole blood and/
or swab samples
Parameter
Patients with positive PCR results 
n = 91
Patients with negative PCR results 
n  =105
Statistical significance of the 
difference
Sex 73 M (80.2%), 16 F (17.6%), 2a (2.2%) 83 M (79.0%), 19 F (18.1%), 3a (2.9%) ns
Age M (median 35) M (median 35) ns
F (median 26.5) F (median 25) ns
Syphilis stage 59 primary (64.8%) 41 primary (39.0%) p = 0.0003
20 secondary (22.0%) 26 secondary (24.8%) ns
8 latent (8.8%) 33 latent (31.4%) p = 0.0001
4 othersb (4.4%) 5 othersb (4.8%) ns
aAnonymous sample.
bCongenital syphilis, tertiary syphilis or not determined stage.
ns: not statistically significant.
Table II. Genetic typing of treponemal DNA isolated from patients with PCR-positive samples
Genotypea TP0136 TP0548
23S rRNA 
geneb
Genotyped patients 
n=64
CDC subtypes (arp and 
tpr gene subtypes)
Typed patients 
n=39
Completely typed patients (n = 49) (n = 35)
SSS Identical to SS14 Identical to SS14 Sensitive 31 11d, 12d, 14d, 14k 20
SSR8 Identical to SS14 Identical to SS14 A2058G 3 14d, 14e 3
SSR9 Identical to SS14 Identical to SS14 A2059G 6 12d, 15d 5
U1SS Unique 1 Identical to SS14 Sensitive 1 8d 1
U2SS Unique 2 Identical to SS14 Sensitive 1 14d 1
SU1S Identical to SS14 Unique 1 Sensitive 1 14p 1
SU2R8 Identical to SS14 Unique 2 A2058G 6 14d 4
Partially typed patients (n=15) (n=4)
XSS Not determined Identical to SS14 Sensitive 4 Not determined Not determined
SXS Identical to SS14 Not determined Sensitive 3 Not determined Not determined
SXR8 Identical to SS14 Not determined A2058G 1 Not determined Not determined
XSR8 Not determined Identical to SS14 A2058G 1 Not determined Not determined
XSR9 Not determined Identical to SS14 A2059G 1 Not determined Not determined
XU2R8 Not determined Unique 2 A2058G 3 14d 2
XU3R8 Not determined Unique 3 A2058G 1 14d 1
XU4R9 Not determined Unique 4 A2059G 1 Not determined d 1
aGenotypes were denoted by a 3-letter code: the 1st letter stands for TP0136 sequence (S, identical to SS14; U1, unique sequence 1; X, not determined), the 
2nd letter stands for TP0548 sequence (S, identical to SS14; U1, unique sequence 1; X, not determined), and the 3rd letter stands for sensitivity to macrolide 
antibiotics (S, sensitive; R8, mutation A2058G; R9, mutation A2059G).
bThe SS14 strain confers A2058G mutation in the 23S rRNA gene.
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schemes, 14 different subtypes were identified among 
typeable samples taken from 64 patients. 
The 23S rDNA locus was tested in samples isolated 
from 75 patients and in 28 of them (37.3%), either 
A2058G (17 patients) or A2059G (11 patients) muta-
tions were found.
DISCUSSION
Molecular detection of treponemal DNA and the sub-
sequent molecular typing of T. pallidum strains are 
important improvements in syphilis diagnostics for a 
number of reasons, including epidemic characterization 
and control (19, 23, 31–40), association of particular 
strain genotypes with neurosyphilis (23), resistance to 
macrolide antibiotics (25, 27, 38, 40–45), and discrimi-
nation between re-infection and treatment failure (25). 
Since 1998, when the first treponemal DNA typing 
was introduced (19), a number of studies in different 
countries have been performed (23, 31–40). Recently, 
the typing system has been improved (23) by the addition 
of sequencing analysis of the TP0548 gene (20) to the 
originally described typing system. Using this improved 
typing system, the original 14 subtypes have been sepa-
rated into 25 strain types (23) using 15 T. pallidum type 
isolates and clinical samples isolated from 158 syphilis 
patients in USA, China, Ireland, and Madagascar. Our 
typing system involved sequencing of three loci (TP0136, 
TP0548 and 23S rDNA). While sequencing of TP0136 
was found to be unsuitable for molecular typing purpo-
ses (23), we found at least 3 genotypes with respect to 
TP0136 sequences (Fig. 1). This discrepancy could reflect 
the presence of different types of treponemes in different 
geographical areas. Although the 23S rDNA mutations 
are potentially unstable (and therefore not suitable for 
long-term typing), the presence of macrolide-resistance 
causing mutations are of clinical relevance since ma-
crolides are used for syphilis treatment in patients with 
penicillin allergies, especially in pregnant women (46). 
In our study, more than 37% of the strains were found 
to be resistant to macrolide antibiotics and the A2058G 
mutation was found in 22.7% of tested T. pallidum 
strains. As documented in the literature (40–42), the 
incidence of macrolide-resistant A2058G mutation in T. 
pallidum strains was similar or higher in USA and Canada 
(16–41.9%). In 2004, the number of macrolide-resistant 
T. pallidum strains reached 56% in San Francisco (42). 
In Europe, macrolide-resistant T. pallidum strains were 
documented in Dublin, Ireland, with 88% of samples 
Table III. CDC subtypes and their further typing using sequencing 
of TP0136, TP0548, 23S rDNA genes
CDC subtype
Patients 
n
Genotypes based on TP0136, 
TP0548, 23S rDNA genesa
Patients 
n
14d 27 SSS 17
SSR8 2
SU2R8 4
U2SS 1
XU2R8b 2
XU3R8 1
15d 4 SSR9 4
12d 2 SSS 1
SSR9 1
11d 1 SSS 1
8d 1 U1SS 1
14e 1 SSR8 1
14k 1 SSS 1
14p 1 SU1S 1
We were unable to amplify arp gene from the treponemal DNA isolated 
from one patient with XU4R9 genotype and therefore this patient is not 
shown in Table III.
aGenotypes were denoted by a 3-letter code: the 1st letter stands for TP0136 
sequence (S, identical to SS14; U1, unique sequence 1; X, not determined), 
the 2nd letter stands for TP0548 sequence (S, identical to SS14; U1, unique 
sequence 1; X, not determined), and the 3rd letter stands for sensitivity to 
macrolide antibiotics (S, sensitive; R8, mutation A2058G; R9, mutation 
A2059G).
bXU2R8 genotype was not considered as unique genotype because it cannot 
be differentiated from the SU2R8 genotype.
Fig. 1. Nucleotide sequences of treponemal TP0136 
and TP0548 loci identified among clinical samples 
isolated in the Czech Republic between 2004 and 
2010. Please note that the TP0136 unique sequence 
1 was determined between coordinates 303 and 1452, 
while TP0136 unique sequence 2 between coordinates 
628 and 1452. Coordinates correspond to the positions 
in the SS14 genome (16). Nucleotides different from 
the SS14 sequences are shown in bold.
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carrying the A2058G mutation (27). In Shanghai, China, 
all 38 investigated patients with syphilis were found to 
contain treponemal DNA with the A2058G mutation (38). 
In contrast, not a single strain having mutation A2058G 
was identified among 141 tested samples of treponemal 
DNA isolated in Madagascar (45). The incidence of 
macrolide-resistant T. pallidum strains thus appears to 
be geographically specific and increasing in time. How-
ever, it is not known whether the increased incidence of 
macrolide-resistant strains is due to accumulation of new 
mutations or expansion of macrolide resistant strains.
For assessment of stability of the 23S rDNA locus 
in the human population, a documented transfer of 
macrolide sensitive strains would be required. In our 
group of patients, we were able to document 5 indivi-
dual transmissions of T. pallidum strain SSS from one 
patient to another through identified contacts between 
8 patients during a time period up to 31 days (data not 
shown). Both heterosexual (4 cases) and homosexual 
transmissions (1 case) were followed. In all patients, the 
identical genotype (SSS) was identified, suggesting that 
susceptibility to macrolide antibiotics could be stable 
enough to follow transmission of T. pallidum amongst 
several patients. 
Three out of the 4 most abundant genotypes (SSS, 
SSR8, and SSR9), can be further classified based 
on the CDC typing scheme (19) to 2 to 4 additional 
subgroups (Table II and III). This observation is also 
in contradiction to the proposed instability of the 23S 
rDNA loci (23). If the SSS subtype was a genotype with 
easily induced mutations in the 23S rRNA gene, then 
genetic homogeneity between the SSS and the SSR8 
and SSR9 groups in the number of repetitions in the 
arp gene and polymorphisms in the tpr genes would be 
expected, unless these traits were genetically unstable. 
In fact, diverse arp and tpr genotypes were found in 
SSS, SSR8 and SSR9 groups and the variants of arp 
and tpr genes (as a basis of CDC typing system) appear 
to combine independently with sequence variants of 
TP0136, TP0548 and 23S rRNA genes.
In a recent paper by Marra et al. (23), the TP0548 
gene sequence (within nucleotides 131–215) was used to 
further type (in addition to arp and tpr subtypes; 19) tre-
ponemal DNA. Analysis of 131–215 nt region of TP0548 
differentiated our samples into 2 groups (subtypes f and 
g according to Marra et al. (23)), whereas sequencing of 
TP0548 within nucleotides 131–525 revealed 5 geno-
types, indicating that the TP0548 locus can be used for 
more detailed typing of, at least, samples from certain 
geographical regions. Interestingly, treponemal strains 
similar to both Nichols (TP0548 variants c and d accor-
ding to Marra et al. (23)) and SS14 (TP0548 variants e, f, 
g and i) strains were found in the USA and Ireland, while 
only SS14-like strain variants f and g were found in the 
Czech Republic. In further studies, a greater number of 
clinical strains of different geographical origin should 
be tested together with parallel samples taken from the 
same patient to critically assess the stability of a particular 
genotypic trait and treponemal intra-strain variability. 
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